About the Division

The HIlda and J. Lester Gabrilove Division of Endocrinology, Diabetes and Bone Disease provides care for patients with endocrine diseases, including diabetes, throughout New York City by unifying protocols, programs, and treatments through outreach, education, and innovative community-based programs.

The Division is at the forefront of cutting-edge research on endocrine diseases and diabetes. It trains future leaders and innovators in the field of endocrinology through a world-renowned fellowship program, and is developing innovative quality improvement programs to achieve the highest quality standards in diabetes and endocrine patient care.

The Mount Sinai Diabetes, Obesity, and Metabolism Institute at the Icahn School of Medicine at Mount Sinai was created to find a cure and to develop better therapeutic and prevention strategies for those who experience diabetes, obesity, and metabolic syndromes. Physician-scientists from various specialties across the Mount Sinai Health System, including endocrinology, surgery, genetics and genomics, and pharmacology and systems therapeutics, are conducting groundbreaking research to revolutionize the approach to all metabolic disorders.

System Chief: Andrea Dunaif, MD
Lillian and Henry M. Stratton Professor of Molecular Medicine